Search Results - "Eugene B. Buynak"
-
1
Human hepatitis B vaccine from recombinant yeast
Published in Nature (London) (01-01-1984)“…The worldwide importance of human hepatitis B virus infection and the toll it takes in chronic liver disease, cirrhosis and hepatocarcinoma, make it imperative…”
Get full text
Journal Article -
2
Live attenuated varicella virus vaccine. Efficacy trial in healthy children
Published in The New England journal of medicine (31-05-1984)“…We conducted a double-blind, placebo-controlled efficacy trial of the live attenuated Oka/Merck varicella vaccine among 956 children between the ages of 1 and…”
Get more information
Journal Article -
3
Vaccine Against Human Hepatitis B
Published in JAMA : the journal of the American Medical Association (11-12-1996)“…• A highly purified and inactivated vaccine was made of hepatitis B virus surface antigen. The vaccine was tested exhaustively for safety by ordinary…”
Get full text
Journal Article -
4
Clinical Evaluation in Healthy Adults of a Hepatitis B Vaccine Made by Recombinant DNA
Published in JAMA : the journal of the American Medical Association (01-06-1984)“…A vaccine formulated from hepatitis B surface antigen (HBsAg) produced by a recombinant strain of the yeast Saccharomyces cerevisiae was administered to two…”
Get full text
Journal Article -
5
Vaccine Against Human Hepatitis B
Published in JAMA : the journal of the American Medical Association (28-06-1976)“…A highly purified and inactivated vaccine was made of hepatitis B virus surface antigen. The vaccine was tested exhaustively for safety by ordinary procedures…”
Get full text
Journal Article -
6
Development and Evaluation of the Moraten Measles Virus Vaccine
Published in JAMA : the journal of the American Medical Association (14-10-1968)“…Clinical reaction rates and antibody responses were compared in children given three vaccines: Enders' live, attenuated Edmonston B measles vaccine; a newly…”
Get full text
Journal Article -
7
Live, attenuated mumps-virus vaccine
Published in The New England journal of medicine (01-02-1968)Get more information
Journal Article -
8
Influence of Age on Clinical Response to HPV-77 Duck Rubella Vaccine
Published in JAMA : the journal of the American Medical Association (13-11-1972)“…The involvement of the joints that may follow immunization with live rubella virus vaccines is strongly age-related. The present policy of extending…”
Get full text
Journal Article -
9
Rubella vaccination in adult females
Published in The New England journal of medicine (27-03-1969)Get more information
Journal Article -
10
Trivalent Combined Measles-Mumps-Rubella Vaccine: Findings in Clinical-Laboratory Studies
Published in JAMA : the journal of the American Medical Association (04-10-1971)“…Four lots of combined trivalent Moraten measles, Jeryl Lynn mumps, and HPV-77 duck rubella vaccine were administered to a total of 715 children, 7 months to 7…”
Get full text
Journal Article -
11
Combined Live Measles, Mumps, and Rubella Virus Vaccines
Published in JAMA : the journal of the American Medical Association (24-03-1969)“…Combined trivalent Moraten measles, Jeryl Lynn mumps, and HPV-77 duck embryo rubella vaccine, as well as combined bivalent Moraten measles and Jeryl Lynn mumps…”
Get full text
Journal Article -
12
Live Attenuated Rubella Virus Vaccines Prepared in Duck Embryo Cell Culture: I. Development and Clinical Testing
Published in JAMA : the journal of the American Medical Association (15-04-1968)“…Merck strain rubella virus and Meyer-Parkman monkey kidney attenuated HPV-77 virus were prepared at various levels of attenuation for investigative use in…”
Get full text
Journal Article -
13
Live Attenuated Rubella Virus Vaccines Prepared in Duck Embryo Cell Culture: II. Clinical Tests in Families and in an Institution
Published in JAMA : the journal of the American Medical Association (19-08-1968)“…Duck embryo cell culture rubella virus vaccines prepared with the HPV-77 (Meyer-Parkman) and the Merck (B-level attenuation) strains of virus were evaluated in…”
Get full text
Journal Article -
14
Combined Live Rubella-Mumps Virus Vaccine Findings in Clinical-Laboratory Studies
Published in JAMA : the journal of the American Medical Association (10-05-1971)“…Four lots of combined bivalent HPV-77 duck rubella-Jeryl Lynn mumps vaccine (Biavax) were administered to a total of 415 children 7 months to 7 years of age…”
Get full text
Journal Article -
15
Administration of Enders' Live Measles Virus Vaccine with Human Immune Globulin
Published in JAMA : the journal of the American Medical Association (30-06-1962)“…Extensive investigations have proved the efficacy and safety of Enders' live measles virus vaccine coadministered with measles antibody in human immune…”
Get full text
Journal Article -
16
Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization
Published in The New England journal of medicine (27-07-1961)Get more information
Journal Article -
17
Live, attenuated rubella-virus vaccine
Published in The New England journal of medicine (08-08-1968)Get more information
Journal Article -
18
Jeryl Lynn Strain Live Attenuated Mumps Virus Vaccine: Influence of Age, Virus Dose, Lot, and γGlobulin Administration on Response
Published in JAMA : the journal of the American Medical Association (01-01-1968)“…The influence of age, virus dose, lot, and γ-globulin administration on serologic and clinical responses to Jeryl Lynn strain live attenuated mumps virus…”
Get full text
Journal Article -
19
Jeryl Lynn Strain Live Mumps Virus Vaccine: Durable Immunity for Three Years Following Vaccination
Published in JAMA : the journal of the American Medical Association (03-03-1969)“…Neutralizing antibody following Jeryl Lynn strain live mumps virus vaccine persisted for at least three years following vaccination without substantial decline…”
Get full text
Journal Article -
20
Use of living attenuated measles-virus vaccine in early infancy
Published in The New England journal of medicine (04-08-1960)Get more information
Journal Article